Solidion Technology
STINASDAQUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $4.03 Prior regular-session close from the quote source.
- $4.04–$4.25 Regular-session low and high so far today.
- 43.1K Regular-session shares traded · Nov 11, 4:00 PM ET.
- Not yet confirmed The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
- $2.94–$46.00 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own STI if its electrical/battery technology becomes partner-funded customer revenue before the balance sheet forces highly dilutive capital.
STI price history
Loading recent earnings…
Investment thesis
What must happen next
Solidion’s technology must move from proof-of-concept or sample activity into repeat customer adoption; otherwise the company remains an R&D story rather than a commercial supplier.WeakeningMateriality: High
FY2025 GAAP annual revenue was $13,350, above FY2023 GAAP annual revenue of $6,944, showing some commercial activity exists. If customer validation arrives, the revenue base can start to matter; if it does not, the equity is mostly financing risk attached to unproven technology.
Watch: EV, storage, or industrial customers choose incumbent lithium-ion and electrical-equipment suppliers instead of qualifying Solidion’s technology.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 GAAP annual revenue was $13,350, above FY2023 GAAP annual revenue of $6,944, showing some commercial activity exists.
Open source ↗Access to outside capital or strategic-partner funding is the gating operating capability because Solidion’s current cash resources cannot support the burn needed to commercialize the technology.WeakeningMateriality: High
Cash was $204,725 at FY2025 year-end. If financing is available on tolerable terms, the company buys time to prove demand; if not, shareholders face dilution, distress, or a stalled roadmap.
Watch: Public equity markets refuse to fund microcap battery-technology issuers except through deeply discounted or warrant-heavy structures.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Cash was $204,725 at FY2025 year-end.
Open source ↗The company likely needs a partner-led or licensing commercialization model, because its asset base appears too small to support internally funded manufacturing scale-up.HoldingMateriality: Medium
FY2025 total assets were $4,796,854. A partner-led model could preserve upside with limited capital; a requirement to self-manufacture would likely overwhelm the balance sheet.
Watch: Customers require Solidion-owned pilot lines, manufacturing capacity, quality systems, or field-support infrastructure before awarding business.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 total assets were $4,796,854.
Open source ↗Per-share value creation requires recapitalizing the balance sheet without giving most of the commercialization upside to creditors, preferred holders, warrant holders, or new investors.WeakeningMateriality: Medium
FY2025 stockholders’ equity was negative $7,185,574. Even if the technology ultimately works, common shareholders can lose if the rescue financing captures the economics first.
Watch: The company raises capital through highly dilutive common stock, warrants, convertible notes, or preferred securities.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 stockholders’ equity was negative $7,185,574.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Solidion’s technology must move from proof-of-concept or sample activity into repeat customer adoption; otherwise the company remains an R&D story rather than a commercial supplier. If customer validation arrives, the revenue base can start to matter; if it does not, the equity is mostly financing risk attached to unproven technology.
Access to outside capital or strategic-partner funding is the gating operating capability because Solidion’s current cash resources cannot support the burn needed to commercialize the technology. If financing is available on tolerable terms, the company buys time to prove demand; if not, shareholders face dilution, distress, or a stalled roadmap.
The company likely needs a partner-led or licensing commercialization model, because its asset base appears too small to support internally funded manufacturing scale-up. A partner-led model could preserve upside with limited capital; a requirement to self-manufacture would likely overwhelm the balance sheet.
Per-share value creation requires recapitalizing the balance sheet without giving most of the commercialization upside to creditors, preferred holders, warrant holders, or new investors. Even if the technology ultimately works, common shareholders can lose if the rescue financing captures the economics first.
All standing thesis claims
Original report summary
its electrical/battery technology becomes partner-funded customer revenue before the balance sheet forces highly dilutive capital.
Bull case and bear case
Bull case and bear case for Solidion Technology
Where the evidence on Solidion Technology disagrees: Mixed on the latest evidence (Nov 4, 2026). Of its 4 thesis points, 1 holding and 3 weakening.
Bull case: what the evidence supports
The company likely needs a partner-led or licensing commercialization model, because its asset base appears too small to support internally funded manufacturing scale-up.
Bear case: what the evidence questions
Solidion’s technology must move from proof-of-concept or sample activity into repeat customer adoption; otherwise the company remains an R&D story rather than a commercial supplier.
Access to outside capital or strategic-partner funding is the gating operating capability because Solidion’s current cash resources cannot support the burn needed to commercialize the technology.
Per-share value creation requires recapitalizing the balance sheet without giving most of the commercialization upside to creditors, preferred holders, warrant holders, or new investors.
Thesis-Break Engine
Thesis-break watch · Solidion Technology
No break has crossed Solidion Technology’s thesis. Its break conditions are checked against every new filing as it lands.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedRegulation FD disclosure.
Solidion Technology filed an SEC 8-K on 2026-09-21: Regulation FD disclosure. It is a dated development that tests the current thesis.
- MixedDirector or principal officer change.
Solidion Technology filed an SEC 8-K on 2026-09-02: Director or principal officer change. It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
Solidion Technology filed an SEC 8-K on 2026-08-12: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- EV, storage, or industrial customers choose incumbent lithium-ion and electrical-equipment suppliers instead of qualifying Solidion’s technology.
- Public equity markets refuse to fund microcap battery-technology issuers except through deeply discounted or warrant-heavy structures.
- Customers require Solidion-owned pilot lines, manufacturing capacity, quality systems, or field-support infrastructure before awarding business.
- The company raises capital through highly dilutive common stock, warrants, convertible notes, or preferred securities.
STI news
Loading headlines…
Financial statements
STI income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
STI: quick answers
- What is STI's short interest?
- As of October 30, 2026, 243,947 STI shares were sold short, 2.59% of its shares outstanding, down 10.3% from the count before. At the stock's average daily volume that is 3.2 days to cover. FINRA publishes the count twice a month. STI short interest history
- Have members of Congress traded STI?
- 19 trades in STI have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed STI trade